News Center
October 15, 2024
Variantyx Combines Long and Short Reads for Rare Disease Whole-Genome Diagnostic Test
- By Variantyx
- Posted in General Company Updates
GenomeWeb recently wrote a profile on Genomic Unity 2.0® – the first commercially available test to incorporate third-generation long-read Oxford...
September 18, 2024
Variantyx Brings the First Combined Short- and Long-Read Whole Genome Sequencing Test to Market with Genomic Unity® 2.0
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. September 18, 2024 (Business Wire) – Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic...
April 26, 2024
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. April 26, 2024 (Business Wire) – Variantyx, a leader in molecular diagnostics, announced today that it has secured...
November 30, 2023
Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...
November 10, 2023
Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
October 18, 2023
Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...
April 5, 2023
Variantyx welcomes two new Novaseq XPlus sequencers
- By Variantyx
- Posted in General Company Updates
Today we officially welcomed two new Illumina Novaseq XPlus sequencers with a company-wide ribbon cutting ceremony. We can’t wait to complete validation (already under way!)…
February 12, 2022
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
- By Variantyx
- Posted in General Company Updates
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...
December 14, 2021
Variantyx Winter Holiday Hours of Operation
- By Variantyx, Inc
- Posted in General Company Updates
Valued Customers, We would like to update you on our winter holiday hours of operation: Our offices will be closed...
November 12, 2021
Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment
- By STUTTGART
- Posted in General Company Updates
STUTTGART, Germany, Nov. 15, 2021 PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...